ESIFLO 250 (Salmeterol (50mcg) + Fluticasone Propionate (250mcg))

Esiflo 250 Transcaps is a medicinal formulation that combines two active ingredients, designed to facilitate easier breathing by widening the air passages in the lungs. This medication is indicated for managing conditions such as asthma, which is characterized by wheezing and difficulty in breathing, as well as chronic obstructive pulmonary disease (COPD), a progressive lung condition that restricts airflow. It is important to follow your healthcare provider’s instructions regarding the frequency of use for your inhaler. While some effects may be observed within a few days, it is essential to understand that the full benefits typically take several weeks to manifest. Consistent use of this medication is crucial for maintaining its efficacy, even in the absence of symptoms, as discontinuation may lead to deterioration of asthma or COPD symptoms. It is not intended for immediate relief during acute asthma episodes; in such cases, a rescue inhaler should be utilized. To optimize the medication’s effectiveness, proper inhaler technique should be employed. Common adverse reactions may include nausea, vomiting, respiratory infections, oral fungal infections, headaches, hoarseness, sore throat, coughing, musculoskeletal pain, and elevated heart rate. If these effects occur, it is advised not to discontinue use but to consult your healthcare provider. Preventive measures, such as rinsing the mouth after use, can help minimize some side effects. Furthermore, individuals should be mindful of avoiding triggers that exacerbate asthma and should refrain from smoking. It is crucial to discuss any existing kidney or liver conditions with your doctor prior to initiating treatment.